FORWARD FEATURES CALENDAR

Deals

Arma Partners advises Bregal Unternehmerkapital on majority recapitalisation of proALPHA by ICG

Arma Partners has acted as the exclusive financial advisor to Bregal Unternehmerkapital on the majority recapitalisation of its portfolio company proALPHA Business Solutions by Intermediate Capital Group (ICG). Bregal will remain involved in the further development of proALPHA through a continuing interest alongside ICG, strengthening proALPHA’s shareholder structure with long-term

BTG Corporate Finance advises Japanese manufacturer on two British acquisitions

IMV Europe Limited, part of Osaka based IMV Corporation which manufactures noise and vibration test equipment and has turnover of JPY10.3 billion, has simultaneously acquired two businesses; GBP2.1 million turnover Vibratech, and GBP2.4 million turnover CVMSL with advice from Martin Kennedy and Jeff Barber of BTG Corporate Finance in Manchester.

Epidarex Capital’s Confluence Life Sciences acquired by Aclaris Therapeutics

Epidarex Capital (Epidarex), an early stage life science venture capital firm, has sold portfolio company Confluence Life Sciences to Aclaris Therapeutics, for a total deal value of up to USD100 million in up-front and milestone payments.  The Confluence investors are also eligible to receive future payments on royalties on drug

NSR Invest and LendingRobot merge

NSR Invest and LendingRobot have merged to create a new combined independent advisory platform for alternative lending. Lend Core LLC, the parent company of NSR Invest, acquired Algorithmic, and all its assets, including the LendingRobot website and technology. The combination brings together two highly complementary companies, each with an excellent

Stonehenge Capital invests in PosiGen through Invest CT program

Stonehenge Growth Capital has made an investment in PosiGen that will enable the solar company to expand operations in Connecticut and provide clean energy technology to hundreds of low- to moderate-income Connecticut households. Stonehenge Growth Capital, a subsidiary of Stonehenge Capital Company, made the USD5 million investment through the Invest

Sverica Capital Management acquires Women’s Health USA

Sverica Capital Management (Sverica) has acquired a majority interest in Women’s Health USA (WHUSA). The investment is Sverica’s fourth investment from Fund IV. Based in Avon, Connecticut, WHUSA is a national physician practice management organisation focused on women’s health, including OBGYN and In Vitro Fertilisation. WHUSA provides physician practices with

Stonehenge Capital invests in PosiGen through Invest CT program

Stonehenge Growth Capital has made an investment in PosiGen that will enable the solar company to expand operations in Connecticut and provide clean energy technology to hundreds of low- to moderate-income Connecticut households. Stonehenge Growth Capital, a subsidiary of Stonehenge Capital Company, made the USD5 million investment through the Invest

EmergeVest Fund completes first exit

EmergeVest, an international private investment firm, has completed the first inaugural exit from its debut fund, EmergeVest Fund LP. In connection with the successful merger of its portfolio company, JD United Holdings Limited (JDU), with Taiwan-listed Roo Hsing Co, EmergeVest completely exited its investment in JDU, generating more than two-times

Wynnchurch Capital sells Senco

Middle-market private equity firm Wynnchurch Capital has completed the sale of Senco Holdings (Senco) to Kyocera Corporation (KYO), a supplier of cutting tools, industrial ceramics, electronic components, printers, copiers, solar power generating systems, mobile phones and semiconductor packages. Headquartered in Cincinnati, Ohio, Senco is a designer, manufacturer and marketer of

Events

12 November, 2026 – 5:00 pm

Directory Listings